Jean-Jacques Bienaim
2020
Compensation breakdown
Non-Equity Incentive Plan | $1,663,200 |
---|---|
Option Awards | $3,410,347 |
Salary | $1,298,846 |
Stock Awards | $11,650,975 |
Other | $95,765 |
Total | $18,119,133 |
Bienaim received $11.7M in stock awards, accounting for 64% of the total pay in 2020.
Bienaim also received $1.7M in non-equity incentive plan, $3.4M in option awards, $1.3M in salary and $95.8K in other compensation.
Rankings
In 2020, Jean-Jacques Bienaim's compensation ranked 270th out of 13,090 executives tracked by ExecPay. In other words, Bienaim earned more than 97.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 270 | 98th |
Manufacturing | 86 | 99th |
Chemicals And Allied Products | 26 | 99th |
Drugs | 23 | 99th |
Pharmaceutical Preparations | 14 | 99th |
Pay ratio
Jean-Jacques Bienaim's Pay | $18,119,133 |
---|---|
Median Employee's Pay | $181,141 |
Pay Ratio | 100to 1 |
In 2020, the annual total compensation of Jean-Jacques Bienaim was $18,119,133.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $181,141.
The ratio of Jean-Jacques Bienaim's pay to the pay of median employee was therefore 100 to one.
Bienaim's colleagues
We found six more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2020.
2020
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2020
C Guyer
BioMarin Pharmaceutical
Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
2020
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
2020
Robert Baffi
BioMarin Pharmaceutical
Former President of Global Manufacturing and Technical Operations
2020
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
2020
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
News
April 12, 2022
April 13, 2021
April 14, 2020
April 23, 2019